Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with renal impairment

類似資料

• Pharmacokinetics of the soluble guanylate cyclase stimulator riociguat in individuals with hepatic impairment
  著者:: Frey, Reiner, 等
  出版事項: (2013)
• Assessment of the effects of renal impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
  著者:: Frey, Reiner, 等
  出版事項: (2016)
• Assessment of the effects of hepatic impairment and smoking on the pharmacokinetics of a single oral dose of the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
  著者:: Frey, Reiner, 等
  出版事項: (2016)
• Effects of age and gender on the pharmacokinetics of the soluble guanylate cyclase stimulator riociguat
  著者:: Frey, Reiner, 等
  出版事項: (2013)
• Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
  著者:: Frey, Reiner, 等
  出版事項: (2009)